EUVIMEDEUVIMED entdecken
Fallbericht

Fatal hepatitis after pembrolizumab in combination therapy with carboplatin and pemetrexed

Rasmus Strøm Risbjerg, Niels Kristian Aagaard, Lisbet Grønbæk, Signe Hertz Hansen, Katja Maretty Kongstad, Konstantin Kazankov

Ugeskrift for Læger · 2024

DOI: 10.61409/v06240442 ↗

Kurz gefasst

Fallbericht in der Zeitschrift Ugeskrift for Læger, 2024. Verfasst von Rasmus Strøm Risbjerg und 5 weiteren Autor:innen. Beteiligte Einrichtung: Lever-, Mave- og Tarmsygdomme, Aarhus Universitetshospital. Hauptthemen laut MEDLINE: Pemetrexed, Antibodies, Monoclonal, Humanized, Carboplatin, Antineoplastic Combined Chemotherapy Protocols. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 5 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Immunotherapy-induced hepatitis is a well-known and relatively common side effect of immune checkpoint inhibitors. It is usually mild to moderate and responds well to corticosteroids with a full recovery. However, in rare cases, severe liver injury may develop, leading to fulminant liver failure. In this case report, we present a case of acute fulminant liver failure with a fatal outcome despite adequate treatment in a 67-year-old male following a combination therapy of carboplatin, pemetrexed, and pembrolizumab for metastatic lung cancer.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

PemetrexedAntibodies, Monoclonal, HumanizedCarboplatinAntineoplastic Combined Chemotherapy ProtocolsLung NeoplasmsHumansMaleAgedFatal OutcomeChemical and Drug Induced Liver InjuryLiver Failure, AcuteAntineoplastic Agents, Immunological

Substanzen

pembrolizumabPemetrexedAntibodies, Monoclonal, HumanizedCarboplatinAntineoplastic Agents, Immunological

Autor:innen und Institutionen

  • Lever-, Mave- og Tarmsygdomme, Aarhus Universitetshospital.
  • Medicinsk Afdeling, Regionshospitalet Horsens.
  • Klinisk Farmakologi, Aarhus Universitetshospital.
  • Patologi, Aarhus Universitetshospital.

Zitieren

APA

Risbjerg, R. S., Aagaard, N. K., Grønbæk, L., Hansen, S. H., Kongstad, K. M., & Kazankov, K. (2024). Fatal hepatitis after pembrolizumab in combination therapy with carboplatin and pemetrexed. Ugeskrift for Læger. https://doi.org/10.61409/v06240442

Vancouver

Risbjerg RS, Aagaard NK, Grønbæk L, Hansen SH, Kongstad KM, Kazankov K. Fatal hepatitis after pembrolizumab in combination therapy with carboplatin and pemetrexed. Ugeskrift for Læger. 2024. doi:10.61409/v06240442

BibTeX
@article{Risbjerg2024,
  author = {Risbjerg, Rasmus Strøm and Aagaard, Niels Kristian and Grønbæk, Lisbet and Hansen, Signe Hertz and Kongstad, Katja Maretty and Kazankov, Konstantin},
  title = {Fatal hepatitis after pembrolizumab in combination therapy with carboplatin and pemetrexed},
  journal = {Ugeskrift for Læger},
  year = {2024},
  doi = {10.61409/v06240442}
}
Kostenlos starten →